bubsmark, the info coming up is a conclusion to a clinical trial- results due in August. Given the history of the company and its trial, it is likely, in my view, that the trial will be successful.
There is also this successful colonoscopy trial:
http://www.sciencedirect.com/science/article/pii/S0016510713019822
The trial found that Penthrox was as affective as IV sedation, but also found, re Penthrox:
http://www.gastroenterologyupdate.com.au/latest-news/patient-managed-pain-effective-in-colonoscopy
"Patients in the driving seat of their pain relief were also more likely to remember the results of their procedure and did not run the risk of respiratory depression often associated with IV sedation. They also experienced shorter recovery times and were discharged on average 15 minutes earlier than sedated patients, the gastroenterologists from the Royal Adelaide Hospital reported."
____________
All good stuff.
- Forums
- ASX - By Stock
- MVP
- some research
some research, page-22
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MVP (ASX) to my watchlist
|
|||||
Last
47.8¢ |
Change
0.003(0.53%) |
Mkt cap ! $41.21M |
Open | High | Low | Value | Volume |
48.0¢ | 51.5¢ | 47.0¢ | $15.68K | 32.55K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 23325 | 47.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
48.0¢ | 375 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 23325 | 0.475 |
5 | 10216 | 0.470 |
1 | 10000 | 0.465 |
1 | 6711 | 0.460 |
1 | 30000 | 0.455 |
Price($) | Vol. | No. |
---|---|---|
0.480 | 375 | 1 |
0.540 | 900 | 1 |
0.545 | 20000 | 1 |
0.550 | 22205 | 1 |
0.560 | 100 | 1 |
Last trade - 15.59pm 12/07/2024 (20 minute delay) ? |
Featured News
MVP (ASX) Chart |